ArticleOncotarget2014

Synergistic anti-tumor activity of acadesine (AICAR) in combination with the anti-CD20 monoclonal antibody rituximab in in vivo and in vitro models of mantle cell lymphoma.

Arnau Montraveta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.